Samsung Bioepis and ATLATL Sign MoU to Boost Early-Stage Biotech Innovation in Asia-Pacific
Samsung Bioepis partners with ATLATL to accelerate early-stage biotech innovation in Asia-Pacific, leveraging R&D expertise to support startups and advance breakthrough technologies.
Samsung Bioepis ATLATL Partnership | 30/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy